Aurora is providing pro bono communications support to the Association of Medical Research Charities (AMRC), a membership organisation of the leading medical research charities in the UK, following a pitch process run through the Healthcare Communications Association.
This is a pivotal time for UK medical research following an unprecedented shortfall in charitable funding in the wake of the coronavirus pandemic. We have been highlighting this important issue throughout the year (see here and here), so are especially pleased to have been selected to support the AMRC in making its case to the Government for financial support.
“We are excited to be working with Aurora at this pivotal moment in time for medical research charities in the UK. Now, more than ever, it is important that we communicate the vital role of our charity members in providing hope for millions of patients, young and old, and their families who live with challenging and life-threatening diseases for which there are limited or no treatments available today.”
– Carol Bewick, Director of Membership Engagement and Communications at AMRC
Crucial discovery work for new treatments
AMRC’s members focus their research efforts on early-stage scientific discovery that other participants in our health system, such as pharmaceutical companies and the NHS, aren’t able to address effectively. This early-stage research is the essential first step towards discovering new treatments, as this is where initial discoveries are made that may later evolve into approved new therapies.
Without this crucial discovery work, hope – in the form of safe, effective treatments for the small numbers of people living with rare conditions, as well as the millions who live with prominent diseases like cancer – will diminish or disappear entirely.
Our unshakeable desire to improve lives and prove it
At the core of Aurora’s ethos is the belief that our work only matters if it makes a difference. After many years in healthcare, we still have an unshakeable desire to improve lives and prove it through evidence-based strategies, measurable tactics and quantified outcomes.
We feel privileged to have been selected by the AMRC to partner with them on their mission to secure funding for their members. Through our work, we have seen first-hand the impact of the pandemic on patients’ lives and we are excited to use our expertise to help make a difference for medical research and patients across the UK.
Want to know more?
If you would like to discuss how we can make a difference for you, please get in touch with Sophie.Thompson@auroracomms.com